Skip to content
DEMO
Demo mode: simulated data, for showcase only
Markets
Home
Search
Portfolio
Trending
New
All
Live
Politics
Sports
Culture
Crypto
Economics
Companies
Climate
Tech & Science
World
Media
Trending
New
All
Live
Politics
Sports
Culture
Crypto
Economics
Companies
Climate
Tech & Science
World
Media
Tech & Science Markets | Drazill
Markets
All Tech & Science
Technology
AI & ML
Space
Science
Health & Biotech
Tech & Science
/
Health & Biotech
All
Technology
AI & ML
Space
Science
Health & Biotech
Health & Biotech
Volume
$683.1K
Traders
1,194
Closes
3mo
FDA approves Novo's CagriSema in 2026?
Yes
7
0
¢
No
3
0
¢
All-time price history
YES
-4%
Trade
WHO declares an H5N1 pandemic in 2026?
GLP-1 obesity market leader end of 2026?
FDA approves Novo's CagriSema in 2026?
7
0
¢
3
0
¢
Yes
70¢
No
30¢
$683K
3mo
GLP-1 obesity market leader end of 2026?
Eli Lilly
4
2
¢
Yes
42¢
No
58¢
Novo Nordisk
3
3
¢
Yes
33¢
No
67¢
Another company
2
5
¢
Yes
25¢
No
75¢
$614K
6mo
WHO declares an H5N1 pandemic in 2026?
4
3
¢
5
7
¢
Yes
43¢
No
57¢
$573K
5mo
FDA approves a new CRISPR therapy in 2026?
4
4
¢
5
6
¢
Yes
44¢
No
56¢
$318K
5mo
A GLP-1 pill outsells injectables in 2026?
4
1
¢
5
9
¢
Yes
41¢
No
59¢
$287K
5mo
Wegovy revenue tops $10B in 2026?
2
8
¢
7
2
¢
Yes
28¢
No
72¢
$284K
6mo
FDA novel Alzheimer's approvals in 2026?
Zero
5
7
¢
Yes
57¢
No
43¢
Two or more
3
0
¢
Yes
30¢
No
70¢
One
1
3
¢
Yes
13¢
No
87¢
$244K
5mo
Eli Lilly hits a $1T market cap in 2026?
3
7
¢
6
3
¢
Yes
37¢
No
63¢
$257K
5mo
Demo mode: simulated data, for showcase onlyDemo mode: simulated data, for showcase onlyDemo mode: simulated data, for showcase only
